Cardiology

The daily oral capsule was shown to reduce overweight and obese patient weight by about 6% over 6 months.

Fewer heart disease-related deaths occur in counties where Medicaid was expanded under the Affordable Care Act, according to a provocative new study.

Additionally, the added sugar labels will save the health care system an estimated $31 billion.

About 4 million Americans can’t tolerate statins. A new study suggests bempedoic acid could be used to help these patients lower their LDL cholesterol.

The CREDENCE study of canagliflozin in adults with chronic kidney disease and type 2 diabetes met its primary endpoint as well as cardiovascular endpoints.

Time-restricted feeding has been shown in early trials to be a beneficial treatment for various cardiovascular disease risk metrics.

Study finds that, despite the creation of the Hospital Readmissions Reduction Program, US and Canada saw similar declines in HF readmission rates.

Sleep habits are an overlooked aspect of primary care visits, despite the prevalence and burden of conditions such like insomnia on the general population.

More evidence for the biomarker ctDNA to test for the presence of a rare, but deadly cancer in organ transplant patients was presented at ISHLT annual meeting this month.

Ivabradine can be an important tool to lower heart rates in patients with heart failure, but a new study finds usage rates are low when physicians aren’t proactive about initiating the therapy.

Investigators have found that despite improvements in women’s cardiovascular health care, black women still face disparities in care compared to white and Hispanic women.

By applying research-supported practices, Optimal Hospital has increased patient sleep, improved HCAHPS scores, and decreased length of stay and readmissions.

Patients in the Optimal Hospital wing are given iPads that let them access their medical records, see their care team, and view the schedule of their upcoming tests.

New features include wireless vital monitors, red lighting for nighttime, and surfaces and linens infused with antimicrobial copper.

Ochsner Medical Center's innovative Optimal Hospital initiative has sought to reduce hospital-acquired infections, length of stay, and readmissions.

Investigators evaluated whether volatile anesthetics would translate into better survivability in patients undergoing coronary artery bypass grafting.

Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.

A new study finds it is safe for patients who undergo heart stent procedures to quit taking aspirin at 3 months so long as they continue taking a P2Y12 inhibitor.

How and when do you decide whether to prescribe a patient GLP1 agonists or SGLT2 inhibitors?

What are some of the future risks, in terms of cardiovascular health, facing the average patient?

Insight regarding the recent change to aspirin guidelines and what it means for patients from platelet specialist Jeffrey Berger, MD.

The oral tablet generics approvals also come with 2 approved shared system REMS programs for ambrisentan.

Barbhaiya talks about what he considers to be misleading success rates for Afib ablation being published in studies.

Discussing the implications and future of wearable technology after the release of the Apple Heart Study.

The application to the FDA for icosapent ethyl seeks a new indication to reduce the risk of major adverse cardiovascular events.

MD Magazine sat down with Chirag Barbhaiya, MD, of NYU Langone Health, to discuss the updated guidelines for treating a patient with Afib.

A study of patients recommended for statin therapy under ACC/AHA guidelines, but not taking any, found that 59.2% reported never being offered a statin.

A new cohort assessment shows white and African American men both have a lifetime hypertension risk of more than 80%.

Investigators observed a 22% and 20% increased risk of heart failure during the 2 most severe influenza seasons.